Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04187833
Title Nivolumab in Combination With Talazoparib in Melanoma and Mutations in BRCA or BRCA-ness Genes
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Case Comprehensive Cancer Center
Indications

melanoma

Therapies

Nivolumab + Talazoparib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center Recruiting Cleveland Ohio 44195 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field